Characteristics | Total patients, n (%) |
---|---|
Age (years) (median, range) | 60 (29–90) |
Gender | |
 Male | 137 (65.6%) |
 Female | 72 (34.4%) |
BMI (kg/m2) (median, range) | |
  ≤ 18.5 | 16 (7.6) |
 18.5–23.9 | 87 (41.4) |
 23.9–27 | 72 (34.3) |
  > 28 | 34 (16.7) |
Timing of metastasis | |
 Synchronous | 117 (55.7) |
 Metachronous | 92 (44.3) |
Liver-only metastases | 133 (63.3) |
Lung-only metastases | 79 (37.6) |
Liver-lung metastases | 12 (5.7) |
Extra-regional lymph nodes metastases | 23 (11) |
No. of involving sites | |
 1 | 90 (42.9) |
  ≥ 2 | 119 (57.1) |
Clinical T stage | |
 T2 | 17 (8.1) |
 T3 | 68 (32.5) |
 T4 | 103 (49.3) |
 Unknown | 21 (10.1) |
Clinical N stage | |
 N0 | 63 (30.1) |
 N1 | 69 (33.0) |
 N2 | 52 (24.9) |
 Unknown | 25 (12.0) |
Primary tumor location | |
 Left | 179 (85.6) |
 Right | 28 (13.4) |
 Unknown | 2 (1) |
WBC | |
 <4 | 25 (12.0) |
 4–10 | 171 (81.8) |
  > 10 | 13 (6.2) |
LMR (median, range) | 3.50 (0.44–69.30) |
NLR (median, range) | 2.36 (0.17–27.74) |
PLR (median, range) | 163.19 (0.00–475.86) |
CA199(ng/ml) | |
 0–40 | 120 (57.4) |
  > 40 | 63 (30.2) |
 Unknown | 26 (12.4) |
CEA (ng/ml) | |
 0–5 | 74 (35.4) |
  > 5 | 120 (57.4) |
 Unknown | 15 (7.2) |
Fibrinogen(G/L) | |
  < 2 | 2 (1.0) |
 2–4 | 140 (67.0) |
  > 4 | 56 (26.7) |
 Unknown | 11 (5.3) |
Treatment | |
 Primary tumor resection | 185 (88.1) |
 Lung resection | 20 (9.5) |
 Liver resection | 43 (20.5) |
 Interventional therapy | 45 (21.5) |
 Radiotherapy | 37 (17.7) |
 Chemotherapy | 175 (83.7) |
 Targeted therapy | 71 (34) |